new_0222_0670|CNTA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0670|CNTA|1|Centessa Pharmaceuticals PLC Total Current Assets (Quarterly) (USD)|Centessa Pharmaceuticals PLC Cash and Short Term Investments (Quarterly) (USD)|Centessa Pharmaceuticals PLC Inventories (Quarterly) (USD)|Centessa Pharmaceuticals PLC Net PP&E (Quarterly) (USD)|Centessa Pharmaceuticals PLC Goodwill and Intangibles (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Liabilities (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Current Liabilities (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Long Term Liabilities (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Deposits (Quarterly) (USD)|Centessa Pharmaceuticals PLC Book Value (Quarterly) (USD)|Centessa Pharmaceuticals PLC Retained Earnings (Quarterly) (USD)|Centessa Pharmaceuticals PLC Treasury Stock (Quarterly) (USD)|Centessa Pharmaceuticals PLC EV to Revenues|Centessa Pharmaceuticals PLC EV to Earnings|Centessa Pharmaceuticals PLC EV to Free Cash Flow|Centessa Pharmaceuticals PLC EV to Assets (Quarterly)|Centessa Pharmaceuticals PLC PS Ratio|Centessa Pharmaceuticals PLC PE Ratio|Centessa Pharmaceuticals PLC Price to Book Value|Centessa Pharmaceuticals PLC PEG Ratio|Centessa Pharmaceuticals PLC Debt to Equity Ratio|Centessa Pharmaceuticals PLC Dividend Yield|Centessa Pharmaceuticals PLC Shareholder Yield (TTM)|Centessa Pharmaceuticals PLC Percent of Shares Outstanding Short|Centessa Pharmaceuticals PLC Total Receivables (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Payables (Quarterly) (USD)|Centessa Pharmaceuticals PLC Total Capital Stock (Quarterly) (USD)|Centessa Pharmaceuticals PLC Return on Invested Capital|Centessa Pharmaceuticals PLC Quality Ratio Score|Centessa Pharmaceuticals PLC Momentum Score|Centessa Pharmaceuticals PLC Beta (1Y)|Centessa Pharmaceuticals PLC Sustainable Growth Rate (TTM)|Centessa Pharmaceuticals PLC Institutional Investor Ownership Percentage|Centessa Pharmaceuticals PLC Average Diluted Shares Outstanding (Quarterly)|Centessa Pharmaceuticals PLC Total Employees (Annual)|Centessa Pharmaceuticals PLC EPS Diluted (Quarterly) (USD)|Centessa Pharmaceuticals PLC Shares Outstanding|Centessa Pharmaceuticals PLC Repurchase of Capital Stock (Quarterly) (USD)|Centessa Pharmaceuticals PLC Ordinary Shares Number (Quarterly)|Centessa Pharmaceuticals PLC Payout Ratio|Centessa Pharmaceuticals PLC Quick Ratio (Quarterly)|Centessa Pharmaceuticals PLC Normalized Diluted EPS (Quarterly) (USD)|Centessa Pharmaceuticals PLC Stock Buybacks (Quarterly) (USD)|Centessa Pharmaceuticals PLC Effective Tax Rate (TTM)|Centessa Pharmaceuticals PLC Return on Equity|Centessa Pharmaceuticals PLC Net Income (TTM) (USD)|Centessa Pharmaceuticals PLC Revenue (TTM) (USD)|Centessa Pharmaceuticals PLC Dividend Per Share (Quarterly) (USD)|Centessa Pharmaceuticals PLC Revenue (Quarterly) (USD)|Centessa Pharmaceuticals PLC Gross Profit (Quarterly) (USD)|Centessa Pharmaceuticals PLC SG&A Expense (Quarterly) (USD)|Centessa Pharmaceuticals PLC Pre-Tax Income (Quarterly) (USD)|Centessa Pharmaceuticals PLC Net Income (Quarterly) (USD)|Centessa Pharmaceuticals PLC Net Interest Income (Quarterly) (USD)|Centessa Pharmaceuticals PLC Price (USD)|Centessa Pharmaceuticals PLC Total Return Price (USD)|Centessa Pharmaceuticals PLC Enterprise Value (USD)|Centessa Pharmaceuticals PLC 30-Day Average Daily Volume|Centessa Pharmaceuticals PLC 1 Year Price Returns (Daily)||
new_0222_0670|CNTA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0670|CNTA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_0222_0670|CNTA|5|91.5|91.5||91.5||91.5|91.5|91.5||91.5|91.5||||||||1.44565217391|||1.44808743169||15.5|91.5|91.5|91.5||||||30.625|92||92|21.875||91.5|||92|||||||||92|92|92|92|1.44565217391|1.44565217391|1.44808743169|1.42857142857|||
new_0222_0670|CNTA|6|2|2||2||2|2|2||2|2||||||||184|||183||16|2|2|2||||||8|1||1|8||2|||1|||||||||1|1|1|1|184|184|183|154|||
new_0222_0670|CNTA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0670|CNTA|202103|313.636|298.612||0.045||41.886|18.977|22.909||30.787|-243.273||||||||61.7625||||||12.954|12.216|247.98||||||0.9364||||87.4244||85.9244||||||||||||||||21.75|21.75|1851.0067||||
new_0222_0670|CNTA|202106|643.682|613.759||0.075||58.115|24.185|33.93||585.642|-284.724||||||||3.4094|||||0.9031|15.304|7.261|0.252||||||62.649|63.5167||-0.65|89.8994||89.8994|||-0.4719|||||||||11.841|-41.451|-41.451|0.027|22.21|22.21|1382.9067|208929.0667||20.64|22.05
new_0222_0670|CNTA|202109|611.645|578.815||0.114||63.074|29.144|33.93||549.133|-324.879||||||||2.734|||||1.3086|21.556|18.456|0.252||||||72.552|89.8995||-0.45|89.9004|-0.012|89.9004|||-0.45|-344.124||||||||12.464|-40.155|-40.155|0.065|16.7|16.7|922.5217|116191.8667||17.2|11.85
new_0222_0670|CNTA|202112|||||||||||||||||||1.8434|||||2.457|||||||||71.7064||||||||||||||||||||||11.26|11.26|433.4691|191380.4333||9.53|9.065